Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
FDA Approval
Q&A: What FDA layoffs mean for MedTech approvals
By
Jessica Hagen
|
12:02 pm |
April 08, 2025
Ben Wolf, partner in Alston & Bird's Health Care Group, told MobiHealthNews how FDA staffing cuts could slow device approvals and what companies can do to stay ahead.